Cresset Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $326K | Buy |
189,273
+111,000
| +142% | +$191K | ﹤0.01% | 1265 |
|
|
2025
Q1 | $261K | Sell |
78,273
-29
| -0% | -$97 | ﹤0.01% | 1379 |
|
|
2024
Q4 | $579K | Sell |
78,302
-2,507
| -3% | -$18.6K | ﹤0.01% | 999 |
|
|
2024
Q3 | $759K | Buy |
80,809
+866
| +1% | +$8.13K | ﹤0.01% | 1273 |
|
|
2024
Q2 | $641K | Buy |
79,943
+8,917
| +13% | +$71.5K | ﹤0.01% | 1289 |
|
|
2024
Q1 | $1.05M | Sell |
71,026
-5,714
| -7% | -$84.7K | 0.01% | 935 |
|
|
2023
Q4 | $624K | Buy |
76,740
+31,172
| +68% | +$253K | ﹤0.01% | 1090 |
|
|
2023
Q3 | $207K | Buy |
45,568
+13,276
| +41% | +$60.4K | ﹤0.01% | 1572 |
|
|
2023
Q2 | $227K | Buy |
32,292
+1,292
| +4% | +$9.1K | ﹤0.01% | 1537 |
|
|
2023
Q1 | $189K | Hold |
31,000
| – | – | ﹤0.01% | 749 |
|
|
2022
Q4 | $198K | Sell |
31,000
-14,000
| -31% | -$89.5K | ﹤0.01% | 638 |
|
|
2022
Q3 | $431K | Buy |
45,000
+20,968
| +87% | +$201K | 0.01% | 557 |
|
|
2022
Q2 | $265K | Sell |
24,032
-4,762
| -17% | -$52.5K | ﹤0.01% | 747 |
|
|
2022
Q1 | $479K | Buy |
28,794
+9,407
| +49% | +$156K | 0.01% | 619 |
|
|
2021
Q4 | $369K | Buy |
19,387
+495
| +3% | +$9.42K | ﹤0.01% | 802 |
|
|
2021
Q3 | $466K | Sell |
18,892
-4,174
| -18% | -$103K | 0.01% | 650 |
|
|
2021
Q2 | $600K | Buy |
23,066
+12,531
| +119% | +$326K | 0.01% | 504 |
|
|
2021
Q1 | $333K | Buy |
+10,535
| New | +$333K | 0.01% | 628 |
|